Modern radiation therapy planning and image-guided radiotherapy using the example of prostate cancer

被引:0
作者
Koerber, Stefan A. [1 ,2 ,3 ]
Beuthien-Baumann, Bettina [4 ]
机构
[1] Univ Klinikum Heidelberg, Klin Radioonkol & Strahlentherapie, Neuenheimer Feld 400, D-69120 Heidelberg, Germany
[2] Natl Ctr Tumorerkrankungen NCT, Heidelberg, Germany
[3] Heidelberg Inst Radiat Oncol HIRO, Heidelberg, Germany
[4] Deutsch Krebsforschungszentrum DKFZ, Abt Radiol, Heidelberg, Germany
来源
RADIOLOGE | 2021年 / 61卷 / 01期
关键词
Prostate cancer; Multiparametric magnetic resonance imaging; Prostate-specific membrane antigen; Radiotherapy; MR-linac; BEAM COMPUTED-TOMOGRAPHY; TOXICITY; BOOST; CT;
D O I
10.1007/s00117-020-00763-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Clinical/methodical issue Optimizing radiotherapy demands precise delineation of the target structure, not only before but also during the course of radiotherapy. Standard radiological methods For many years, planning of external radiation treatment planning has been based on computer tomography data. Methodological innovations With the advent of image-guided radiotherapy (IGRT), magnetic resonance imaging (MRI) and functional hybrid imaging are increasingly being integrated into radiation treatment planning. The development of the MR-linac can be seen as an innovation. Performance The integration of MRI and hybrid imaging (positron emission tomography [PET]/CT, PET/MRI) in the treatment planning process enables more precise treatment planning due to the better morphological and functional information. The integration of MRI data on the MR-linac in daily position control enables adaptation of the irradiation plan to the current conditions. Achievements Technical innovation such as the MR-linac as well as increasing use of hybrid imaging contribute to the objective of further individualization within (radio)oncology. Practical recommendations Using the example of prostate cancer, the application of prostate-specific membrane antigen (PSMA) ligands and hybrid imaging offers great potential for individualized strategic treatment decisions. The MR-linac appears to be particularly suitable for radiation therapy of prostate cancer. Special attention must be paid to the technical aspects of positioning and data acquisition for the purpose of radiation treatment planning.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [41] A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer
    Li, Ming
    Li, Gao-Feng
    Hou, Xiu-Yu
    Gao, Hong
    Xu, Yong-Gang
    Zhao, Ting
    CHINESE MEDICAL JOURNAL, 2016, 129 (12) : 1447 - 1454
  • [42] NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
    Berlin, Alejandro
    Lalonde, Emilie
    Sykes, Jenna
    Zafarana, Gaetano
    Chu, Kenneth C.
    Ramnarine, Varune R.
    Ishkanian, Adrian
    Sendorek, Dorota H. S.
    Pasic, Ivan
    Lam, Wan L.
    Jurisica, Igor
    van der Kwast, Theo
    Milosevic, Michael
    Boutros, Paul C.
    Bristow, Robert G.
    ONCOTARGET, 2014, 5 (22) : 11081 - 11090
  • [43] Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
    Gill, Suki
    Thomas, Jessica
    Fox, Chris
    Kron, Tomas
    Rolfo, Aldo
    Leahy, Mary
    Chander, Sarat
    Williams, Scott
    Tai, Keen Hun
    Duchesne, Gillian M.
    Foroudi, Farshad
    RADIATION ONCOLOGY, 2011, 6
  • [44] Implementation of daily image-guided radiation therapy using an in-room CT scanner for prostate cancer isocentre localization
    Knight, K.
    Touma, N.
    Zhu, L.
    Duchesne, G. M.
    Cox, J.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2009, 53 (01): : 132 - 138
  • [45] ROLE OF INTRA- OR PERIPROSTATIC CALCIFICATIONS IN IMAGE-GUIDED RADIOTHERAPY FOR PROSTATE CANCER
    Hanna, Samir Abdallah
    Pimenta Neves-Junior, Wellington Furtado
    Marta, Gustavo Nader
    Kalil Haddad, Cecilia Maria
    Fernandes da Silva, Joao Luis
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1208 - 1216
  • [46] Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer
    Cheng, Jonathan C.
    Schultheiss, Timothy E.
    Nguyen, Khanh H.
    Wong, Jeffrey Y. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02): : 351 - 357
  • [47] Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients
    Valeriani, Maurizio
    Carnevale, Alessia
    Agolli, Linda
    Bonome, Paolo
    Montalto, Adelaide
    Nicosia, Luca
    Osti, Mattia F.
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [48] Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
    Suki Gill
    Jessica Thomas
    Chris Fox
    Tomas Kron
    Aldo Rolfo
    Mary Leahy
    Sarat Chander
    Scott Williams
    Keen Hun Tai
    Gillian M Duchesne
    Farshad Foroudi
    Radiation Oncology, 6
  • [49] Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer
    Sbai, A.
    Thariat, J.
    Tachfouti, N.
    Pan, Q.
    Lagrange, J. -L.
    CANCER RADIOTHERAPIE, 2014, 18 (08): : 740 - 744
  • [50] Dose variation during hypofractionated image-guided radiotherapy for prostate cancer: Planned versus delivered
    Murthy, Vedang
    Shukla, Pragya
    Adurkar, Pranjal
    Master, Zubin
    Mahantshetty, Umesh
    Shrivastava, Shyam K.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (02) : 162 - 167